Normal (non-neoplastic) brain tissue was stained negatively or was dimly faint for anti-GRPEL2 staining, whereas a greater GRPEL2 intensity was enhanced at higher-grade gliomas (Figure 3A). This evidence concerns the gene GRPEL2 and central nervous system cancer.